GulfLINK banner
Site Map | Search | Contact Us
LIBRARY
  Overview
Case Narratives
Environmental Exposure Reports
Information Papers
RAND Reports
NEWS ARCHIVE
  Overview
Press Releases
Speeches
HELP FOR VETERANS
  Overview
Medical Information
Medals
The 1990-1991 Gulf War Story
Related Sites
FAQS
  Overview
Depleted Uranium
Khamisiyah
Pyridostigmine Bromide

Declassified Documents

The United States Army Collection

Files Posted on 11 Dec 1996

Memorandum
ascii text
image

BW Vaccination Program Update
ascii text
image

Particle Diameter Micrometers
ascii text
image

POM Dollar Data
ascii text
image

Botulinum Vaccine Status
ascii text
image

MPOD 3821 Chronology
ascii text
image

Biological Defense Concept
ascii text
image

Tips on Conducting the Test
ascii text
image

Distribution of Pamphlets
ascii text
image

Individual Protection POC
ascii text
image

Contaminated Remains 18 January 91
ascii text
image

Meeting of the Ad Hoc Working Group for the Medical Defense Against Biological Warfare
ascii text
image

Potential for Chemical Weapon Use
ascii text
image

BW Vaccine USAMRIID 6 DEC 90
ascii text
image

Transmittal of Policy Memoranda
ascii text
image

CBW Agent Sampling Procedures
ascii text
image

Vaccine Policy Recommendation
ascii text
image

Routing and Transmittal Slip
ascii text
image

Transmittal of Policy Memoranda
ascii text
image

Unsolicited Proposals
ascii text
image

Vaccine Evaluation Team
ascii text
image

Botulinum Tetravalent Anti Serum
ascii text
image

Botulinum Tetravalent Anti Serum
ascii text
image

UK Memo of Appreciation
ascii text
image

Chemical Decontaminable Letter
ascii text
image

Operations Support Directorate
ascii text
image

Chemical Biological Medical Defense 2 Feb 90
ascii text
image

BW Vaccine Surge Meeting 3 DEC 90
ascii text
image

Joint Chemical Warfare Review
ascii text
image

Use of Pyridostigine Bromide - Operation Desert Shield
ascii text
image

Vaccine Production
ascii text
image

Data Facsimile Transmission Request
ascii text
image

Chemical Company Decontamination
ascii text
image

Topical Skin Protectant 15 Jan 91
ascii text
image

Minutes from the General Officer Steering Committee for the Joint Project Office, Biological Defense
ascii text
image

Minutes from the General Officer Steering Committee for the Joint Project Office, Biological Defense
ascii text
image

Minutes of the Desert Shield Biological Warfare Working
ascii text
image

Minutes of Biological Defense Committee Meeting
ascii text
image

Update on Biological Warfare Vaccination and Production Issues 10 DEC 90
ascii text
image

Minutes of the Biological Defense Committee Meeting
ascii text
image

Minutes Desert Shield Biological Warfare Working Group
ascii text
image

Minutes Desert Shield Biological Warfare Hoc Working Group
ascii text
image

Minutes of the Desert Shield Biological Warfare and Medical Issues Review and Ad Hoc Working Group
ascii text
image

Minutes of the Desert Shield Biological Warfare Hoc Working Group
ascii text
image

MOU Concerning Investigational Use of Drugs, Antibiotics, Biologics, and Medical Devices by the DoD
ascii text
image

Mustard Chemical Agent Standards 2000 11 May 90
ascii text
image

Update on Biological Warfare Vaccination and Production Issues 11 DEC 90
ascii text
image

Policy for Antibiotic Use in Anthrax
ascii text
image

Production of Vaccines for Biological Defense
ascii text
image

Projected Vaccine and Antitoxin Production 11 Mar 91
ascii text
image

Rationale for Antibiotics in Prophylaxis Against Inhalation Anthrax
ascii text
image

Recommendation Concerning Use of Ciprofloxacin 17 DEC 90
ascii text
image

Medical Biological Warfare Defense Action Plan for Operation Desert Shield 10 DEC 90
ascii text
image

Recommendations of the Ad Hoc Working Group for the Medical Defense Against Biological Warfare
ascii text
image

Recommended Preventive Countermeasures for Troops Deploying to the Middle East
ascii text
image

Recovery of Biological Warfare Defense Vaccines/Antitoxins
ascii text
image

Request for Milestone Decision Authority Transfer for the Biological Integrated Detection System
ascii text
image

Status of Vaccination Program for Anthrax and Botulinum Toxin and Ciprofloxacin Antibiotic 15 Jan
ascii text
image

Status on Anthrax Vaccine and Botulinum Toxoid Procurement
ascii text
image

Status Report on Biological Warfare Vaccination and Defense Program
ascii text
image

AAR: Meeting of the Ad Hoc Working Group for the Medical Defense Against Biological Warfare
ascii text
image

Medical Defense Against Desert Shield Biological Warfare Threats
ascii text
image

AAR: Meeting of the Ad Hoc Working Group for the Medical Defense Against Biological Warfare
ascii text
image

AAR: Meeting of the Ad Hoc Working Group for the Medical Defense Against Biological Warfare
ascii text
image

AAR: Meeting of the Ad Hoc Working Group for the Medical Defense Against Biological Warfare
ascii text
image

AAR: Inaugural Meeting of Biological Warfare Ad Hoc Working Group
ascii text
image

Informational Brochure Pentavalent Botulinum Toxoid
ascii text
image

Medical Biological Warfare Defense Readiness for US Forces in Operation Desert Shield/Storm
ascii text
image

Medical Defense Against Biological Warfare Agents
ascii text
image

Anthrax Inoculation Message from USCINCCENT 10 DEC 90
ascii text
image

Capability to Identify Use of Biological Warfare Agent
ascii text
image

Funding Requirement for XM28 Collective Protection for Chemical/Biological Hardening of Corps Hospitals
ascii text
image

FY91 Chemical Biological Defense Material Buys
ascii text
image

Medical Biological Warfare Defense Action Plan
ascii text
image

Modification of MOPP Posture for Dusty Agent Threat 15 Aug 90
ascii text
image

Response to the Biological Warfare Threat 20 Aug 90
ascii text
image

Alert Message to Prepare for Initiation of BW Vaccination Program
ascii text
image

BW Vaccine/Antitoxin Production 14 Jan 91
ascii text
image

Interim Medical Doctrine Biological Warfare Defense Against Anthrax and Botulinum Toxin
ascii text
image

Information Brochure Pentavalent (ABCDE) Botulinum Toxoid
ascii text
image

Chemical and Biological Warfare Threats
ascii text
image

Briefing on Biological Warfare Defense Program Desert Shield
ascii text
image

Chemical Biological CB Support for the Emergency Support Teams
ascii text
image

Collection and Transportation Suspected BW Incident Specimen
ascii text
image

Chemical and Biological Warfare Threats
ascii text
image

Status on Anthrax Vaccine and Botulinum Toxoid Procurement
ascii text
image

Interim Doctrine for Use of Chemical Warfare Agent Skin Protectant
ascii text
image

Additional BW Medical Laboratory Capabilities Recommended for the AOR
ascii text
image

Biological Defense Vaccine Production Facility
ascii text
image

Biological Warfare Defense for Operation Desert Storm 30 Jan 91
ascii text
image

Biological Warfare Defense Medical Guidelines
ascii text
image

Biological Warfare Identification and Detection Capabilities
ascii text
image

Biological Warfare Vaccination Guidelines
ascii text
image

Biological Warfare Vaccination Guidelines
ascii text
image

Medical Biological Warfare Defense Action Plan
ascii text
image

Medical Biological Warfare Defense Readiness US Forces in Operation Desert Shield/Storm
ascii text
image

Medical Biological Warfare Defense Doctrine for Operation Desert Shield
ascii text
image

Minutes of Desert Shield Biological Warfare Hoc Working Group
ascii text
image

Plan for Protection of the Army Force Against Endemic Diseases and Biological Warfare Agents with Contingency Vaccines, Toxoids, and Immune Globulin
ascii text
image

Recommendations Concerning Immunization Policies
ascii text
image

Status Report on Biological Warfare Vaccination and Defense Program
ascii text
image

Summary of Correspondence In-Process Review (IPR) for "J-5 Human Monoclonal Antibody'
ascii text
image

Use of Antibiotics in the Medical Defense Against BW Threats
ascii text
image

Medical Biological Warfare Defense Action Plan for Operation Desert Shield 4 DEC 90
ascii text
image

Medical Countermeasures Against Biological Material
ascii text
image

AAR: Inaugural Meeting of Biological Warfare Ad Hoc Working Group
ascii text
image

Meeting of Ad Hoc Working Group for Medical Defense Against Biological Warfare
ascii text
image

Inaugural Meeting of Biological Warfare Ad Hoc Working Group
ascii text
image

Medical Defense Against Biological Warfare Threat EXSUMS
ascii text
image

Priority Movement of Biological Vaccines and Personnel in Support of Operation Desert Shield
ascii text
image

Status on Anthrax Vaccine Botulinum Toxoid Procurement
ascii text
image

NSN 6305 01 178 7903 Pyriostigmine Bromide Tablets 30 Mg, Storage Requirements
ascii text
image

Medical Chemical Defense Materiel Projected FY91 Requirements 1 Nov 90
ascii text
image

Biological Warfare Laboratory Confirmation Capability in the AOR for Operation Desert Shield
ascii text
image

DOD Immunization Program for Biological Warfare Defense
ascii text
image

Topical Skin Protectant for Use in Operation Desert Shield
ascii text
image

Medical Biological Warfare Defense Action Plan for Operation Desert Shield 4 Dec 90
ascii text
image

Medical Chemical Defense Brief 22 Aug 90
ascii text
image

Chemical Antidotes and Pretreatments
ascii text
image

Persistency Times of Chemical Agents on CARC Painted Vehicles and Sand
ascii text
image

Medical Defense Against Biological Material
ascii text
image

Norwegian Modification of Heating Unit Into Cooling
ascii text
image

Ax Vaccine Protective Antigen in 10 Dose Vial 16 Jan 91
ascii text
image

Medical Management of Chemical Casualties Training
ascii text
image

Interim Doctrine for Use of Chemical Warfare Agent Topical Skin Protectant
ascii text
image

Contingency Vaccine Stocks 14 Feb 89
ascii text
image

Interim Doctrine for Use of Chemical Warfare Agent Topical Skin Protectant
ascii text
image

Diagnosis and Treatment of Exotic Diseases of Tactical Importance to USCENTCOM Forces
ascii text
image

Movement of Supplies - Special Project - Operation Desert Shield
ascii text
image

Procurement of Multi Shield Topical Skin Protectant
ascii text
image

Info on Preventive Medicine 4 Oct 90
ascii text
image

Comments Relative to the Use of the Topical Skin Protectant ICD1536
ascii text
image

The Army Surgeon General's Medical Chemical Defense Plan
ascii text
image

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing.

Download a PDF Reader or learn more about PDFs.